The US President has predicted that pharmaceutical prices could drop 30 per cent to 80 per cent in America
Aurobindo Pharma, IPCA Labs, Oil India, Mazagon Dock and GIC RE are the 5 midcap stocks that can potentially surge up to 24% from present levels, suggests technical charts.
Trump tariffs: Blue Jet Healthcare, Aarti Pharmalabs, Marksans Pharma, Ipca, Wockhardt, Ami Organics, Biocon, Piramal Pharma, Lupin, Laurus Labs and Gland Pharma dropped in the range of 3% to 10%
Shares of IPCA Laboratories have yielded a return of 8 per cent in the last six months and nearly 30 per cent in the last one year for its investors
Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per cent
Shares of Eicher Motors, Anant Raj, Coromandel Int'l, Ipca Labs, and Lupin, among others too hit new record highs as the markets rallied higher